Form 4: RxSight Director Juliet Bakker Files Form 4

Juliet Bakker, a Director at RxSight, Inc., has filed a Form 4 detailing transactions related to her beneficial ownership of company stock.

Summary

• Juliet Bakker, a Director of RxSight, Inc., has filed a Form 4 statement of changes in beneficial ownership.
• The filing indicates the acquisition of 37,037 shares of Common Stock on June 17, 2026, through a restricted stock unit (RSU) award.
• These RSUs vest on the earlier of the one-year anniversary of the grant date (June 17, 2026) or the date of the next annual stockholder meeting, provided Bakker remains an Outside Director.
• Following this transaction, Bakker beneficially owns 85,183 shares of common stock, with 1,548 shares held indirectly through a trust where she acts as Investment Trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard disclosure of equity awards to a director and does not contain information about the company's financial performance or strategic direction.

Positives

• Director Juliet Bakker has acquired additional equity in RxSight, Inc. through an RSU award, aligning her interests with the company's performance.
• The vesting schedule for the RSUs encourages continued service as an Outside Director for at least one year.
• Bakker's indirect beneficial ownership through a trust indicates a diversified approach to her holdings.

Risks

• The RSUs are subject to Bakker's continued service as an Outside Director, meaning forfeiture is possible if her directorship ends before vesting.
• The filing notes that Bakker disclaims beneficial ownership of securities held in trust except to the extent of her pecuniary interest, which could imply a complex ownership structure.

Future Outlook

The vesting of the reported RSUs is contingent on the reporting person's continued service as an Outside Director through the applicable vesting dates, which are the one-year anniversary of the grant date or the next annual stockholder meeting.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for directors and officers regarding their equity transactions. This filing by a director of RxSight, Inc. is a routine update on equity holdings and does not inherently signal significant strategic shifts or financial performance changes for the company.

Stakeholder Impact

• Shareholders: The acquisition of equity by a director can be seen as a positive signal of confidence in the company's future, though the amount is relatively small in the context of total outstanding shares.

Next Steps

• Vesting of 100% of the RSUs subject to the award on the earlier of the one-year anniversary of the Date of Grant (June 17, 2026) or the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as an Outside Director.

Key Dates

Keywords

RxSight Inc, RXST, Form 4, Director, Beneficial Ownership, Restricted Stock Units, RSU, Equity Award, Insider Trading, Securities Exchange Act